Cyclin D1 overexpression in non-small cell lung carcinoma: Correlation with Ki67 labelling index and poor cytoplasmic differentiation

Journal of Pathology

Volumn 180, Issue 4, 1996, Pages 395-399

  Mate, José L ^a,d   Ariza, Aurelio ^a   Aracil, Carme ^a   López, Dolores ^b   Isamat, Marc ^c   Pérez Piteira, Javier ^a   Navas Palacios, José J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE L ESPERIT SANT   (Spain)

^c Fundacion Echevarne   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Cyclin D1; Differentiation; Flow cytometry; Immunohistochemistry; Ki67; Non small lung carcinoma

Indexed keywords

CYCLIN B1; CYCLINE; MONOCLONAL ANTIBODY KI 67; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL CYCLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN D1; CYCLINS; CYTOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS;

EID: 0030444281     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199612)180:4<395::AID-PATH688>3.0.CO;2-C     Document Type: Article

References (21)

1. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
2. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991; 350: 512-515.
3. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065.
4. Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, et al. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 1994; 9: 1925-1929.
5. Motokura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta 1993; 1155: 63-78.
6. Kurzrock R, Ku S, Talpaz M. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer 1995; 75: 584-590.
7. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995; 10: 775-778.
8. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Ann J Pathol 1995; 146: 1161-1169.
9. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995; 55: 975-978.
10. Shapiro GI, Edwards CD, Kobzik L, et al. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res 1995; 55: 505-509.
11. Schauer IE, Siriwardana S, Langan TA, Sclafani RA. Cyclin D1 over-expression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc Natl Acad Sci USA 1994; 91: 7827-7831.
12. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994; 74: 152-158.
13. World Health Organization Histological Typing of Lung Tumors, 2nd ed. Am J Clin Palhol 1982; 77: 123-136
14. Vindelov LL, Christensen IJ. A review of techniques and results obtained in one laboratory by an integrated system of methods designed from routine clinical flow cytometry DNA analysis. Cytometry 1990; 11: 753-770.
15. Hiddemann W, Schumann J, Andreff M, et al. Convention on nomenclature for DNA cytometry. Cytometry 1984; 5: 445-446.
16. Shankey TV, Rabionovitch PS, Bagwell B, et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14: 472-477.
17. Gillett C, Fantl V, Smith R, et al. Amplification and Overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54: 1812-1817.
18. Bartkova J, Lukas J, Strauss M, Bartek J. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 1994; 172: 237-245.
19. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995; 55: 949-956.
20. Berenson JR, Koga J, Yang J, Pearl J, Holmes EC, Figlin R and Lung Cancer Study Group. Frequent amplification of the bcl-1 locus in poorly differential squamous cell carcinoma of the lung. Oncogene 1990; 5: 1343-1348.
21. Skapex SX, Rhee J, Spicer DB, Lassar AB. Inhibition of myogenic differentiation in prolifering myoblasts by cyclin D1-dependent kinase. Science 1995; 267: 1022-1024.